NCT04137107 2026-01-26
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 2/3 Active not recruiting
Clinical Trials
3 trialsNCT04560673 2025-12-31
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05311774 2025-12-03
Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain
Assiut University
Phase NA Completed